Shanghai Allist Pharmaceuticals Hits Day Low of CNY 79.51 Amid Price Pressure

Shanghai Allist Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 4.69% on June 8, 2026. The stock reached an intraday low of CNY 79.51, reflecting a challenging trading session for the company. Over the past week, Shanghai Allist has seen a decrease of 9.94%, while its performance over the last month shows a significant drop of 14.95%. Year-to-date, the stock has declined by 22.86%, contrasting sharply with the China Shanghai Composite, which has remained relatively stable with a minor decrease of 0.24%. Despite these short-term fluctuations, Shanghai Allist Pharmaceuticals has demonstrated strong financial metrics in recent quarters. The company reported a robust operating cash flow of CNY 2,163.79 million and a net profit growth of 59.72% in the first half of the year. With a return on equity of 30.78% and a price-to-book ratio of 4.67, the company maintains a solid financial position within the pharmaceuticals and biotechnology sector.